Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Vorinostat|DRUG: Paclitaxel|DRUG: Trastuzumab|DRUG: Doxorubicin|DRUG: Cyclophosphamide|PROCEDURE: Surgery
Sponsor: Albert Einstein College of Medicine
Collaborators: Merck Sharp & Dohme LLC